SUPRIYAPharmaceuticals
Supriya Lifescience Ltd — Quarterly Results & Earnings
₹561.90
-1.58%
Profit Growth YoY9.27%Latest quarter
Sales Growth YoY20.31%Latest quarter
Sales CAGR 5Y17.45%5 year compound
Profit CAGR 5Y20.71%5 year compound
📋
Quarterly Performance
YoY Profit Growth+9.27%
📈 Moderate growth
YoY Sales Growth+20.31%
🔥 Exceptional growth
OPM 5Y Average
35.97%Operating profit margin
EPS Growth 5Y
-14.16%Interest Coverage
131.31Higher = safer debt servicing
ROE
20.75%ROCE
27.46%💡
Growth Analysis
Supriya Lifescience Ltd reported YoY profit growth of 9.27% and revenue growth of 20.31% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 17.45% and profits at 20.71% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Supriya Lifescience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.